Journey Medical (DERM) Change in Accured Expenses (2020 - 2026)
Journey Medical's (DERM) quarterly Change in Accured Expenses came in at -$8000.0 in Q1 2026, down 100.14% YoY from $5.6 million in Q1 2025, and up 99.79% on a QoQ basis from -$3.8 million in Q4 2025.
Journey Medical (DERM) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Change in Accured Expenses data on file, last reported at -$8000.0 in Q1 2026.
- Quarterly Change in Accured Expenses fell 100.14% year-over-year to -$8000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.6 million (down 329.32% YoY) and the FY2025 annual result came in at -$6000.0, up 99.79% from the prior year.
- Change in Accured Expenses grew to -$8000.0 in Q1 2026, from -$3.8 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $5.6 million in Q1 2025 to a low of -$5.6 million in Q2 2025.
- A 5-year average of -$390882.4 and a median of $5000.0 in 2023 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses tumbled 5506.1% — and 2025, when it jumped 10352.78%.
- Tracing DERM's Change in Accured Expenses over 5 years: stood at $1.6 million in 2022, then slumped by 98.63% to $22000.0 in 2023, then soared by 6340.91% to $1.4 million in 2024, then tumbled by 366.83% to -$3.8 million in 2025, then soared by 99.79% to -$8000.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$8000.0 (Q1 2026), -$3.8 million (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Journey Medical | 205.52 Mn | 179.87 Mn | 12.37 Mn | 5.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.73 Mn |
| Jun 30, 2026 | 5.73 Mn |
| Mar 31, 2026 | -8,000.00 |
| Mar 31, 2026 | -8,000.00 |
| Dec 31, 2025 | -3.78 Mn |
| Dec 31, 2025 | -3.78 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Jun 30, 2025 | -5.57 Mn |
| Jun 30, 2025 | -5.57 Mn |
| Mar 31, 2025 | 5.59 Mn |
| Mar 31, 2025 | 5.59 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | 36,000.00 |
| Sep 30, 2024 | 36,000.00 |
| Jun 30, 2024 | -4.60 Mn |
| Jun 30, 2024 | -4.60 Mn |
| Mar 31, 2024 | 219,000.00 |
| Mar 31, 2024 | 219,000.00 |